Abstracts

Assessment and Quantification of Cell Associate Unspliced HIV-1 RNA using RT-ddPCR

Background: Quantification of cell-associated HIV-1 RNA is critical to understanding how HIV-1 latency is established and maintained in a reservoir of infected cells during antiretroviral therapy. Droplet digital polymerase chain reaction (ddPCR) can detect and precisely quantify the target nucleic acids without the need for a calibration curve. Previous studies demonstrated that ddPCR is generally…

Next Generation Plasma HIV-1 RNA Single Copy Assays

Background: A qPCR assay with single copy sensitivity targeting HIV-1 gag (gSCA) has been widely used to quantify plasma HIV-1 RNA below the limit of clinical assays. However, with current extraction methods, gSCA incompletely recovers a spiked internal standard (avian sarcoma virus, RCAS), and fails to efficiently amplify 15-30% of HIV-1 subtype B sequences due…

Using Antibodies to Detect HIV Persistence in Treatment Intensification and Eradication Studies

Background: Quantifying the degree of HIV persistence during therapy is challenging due to low viral burden and the intracellular sequestration of virus. An alternative or complementary approach is to quantify the host response to HIV. HIV incidence assays have been developed to measure antibody (Ab) evolution during HIV seroconversion. We used HIV incidence assays to…

HIV DNA IN PHI ASSOCIATES WITH T CELL IMMUNITY AND PREDICTS DISEASE PROGRESSION AND REBOUND VIRAEMIA

Background: There are no comprehensive analyses of HIV proviral DNA in Primary HIV Infection (PHI) that include inflammation, HIV-specific immunity and clinical progression. We present analyses from the SPARTAC trial characterizing immunological and virological associations with proviral DNA in PHI, and exploring the impact of proviral DNA on clinical progression and virological rebound on stopping…

Plasmacytoid Dendritic Cell Phagocytosis of IgG Anti-p24 Associates With Control of HIV Infection

Background: Defining immune control mechanisms in patients with HIV infection will facilitate the development of HIV vaccines. Slower progression of HIV infection is associated with IgG antibodies to HIV Gag proteins. We have investigated this association by comparing functional characteristics of IgG antibodies to HIV p24, particularly phagocytosis by a plasmacytoid dendritic cell (pDC) cell…

HIV Myeloid-Derived Suppressor Cells Inhibit the Protective Response to Cytomegalovirus

Background: HIV infection is associated with diminished protective responses against opportunistic infections including cytomegalovirus (CMV). In this study, we examined the effect of HIV expanded myeloid derived suppressor cells (MDSCs) on CMV specific effector cells. Methodology: Peripheral blood mononuclear cells (PBMCs) obtained from HIV seronegative, CMV seropositive healthy donors were cultured in presence of heat…

Recruitment of functionally different NK cells to the rectal mucosa in vaccinated macaques

Background: Increasing evidence suggest that HIV can be controlled by Natural Killer cells (NK cells), via multiple mechanisms including antibody dependent cellular cytotoxicity (ADCC). In the RV144 vaccine trial, that showed 31% protection from HIV acquisition, there was an inverse correlation between risk of infection and ADCC, suggesting the importance of NK cells. NKG2A+ NK…